 SALT LAKE CITY, March 10, 2021 GLOBE NEWSWIRE -- Clene Inc. NASDAQ: CLNN along with its subsidiaries, Clene and its wholly owned subsidiary Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company focused on the treatment of neurodegenerative disease using nanocatalysis, today has featured its publicly filed business overview and corporate presentation on M-Vest.com and announced upcoming presentations at the Maxim Group LLC Inaugural 2021 Emerging Growth Virtual Conference hosted by M Vest LLC. 